Guangdong, Tianjin, China Tasly Holding Group is the famous Corporate Investor, which was founded in 1994. The main department of described Corporate Investor is located in the Tianjin. The company was established in Asia in China.
Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2017. The fund is constantly included in 2-6 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most popular portfolio startups of the fund, we may highlight Genova, HOZ Medical, LenoMed Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Pharmaceutical.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Tasly Holding Group, startups are often financed by Legend Capital, ShareLink Capital, Oriza Seed Capital (Oriza Yuandian). The meaningful sponsors for the fund in investment in the same round are SIG China (SIG Asia Investments), Oriental Patron, Northern Light Venture Capital. In the next rounds fund is usually obtained by Volcanics Venture, Qianhai Fund of Funds, Milestone.
Related Funds
| Fund Name | Location |
| Apollo Investment Corporation | New York, New York, United States |
| CFT Capital | - |
| CreatiFi | - |
| DLB Capital | Connecticut, United States, Wilton |
| Double Sharp Partners | Japan, Minato |
| Emergent Ventures | Connecticut, Sandy Hook, United States |
| GNYHA Ventures | - |
| Jiayuan | Beijing, Beijing, China |
| L&T Infrastructure Finance | India, Maharashtra, Mumbai |
| LOI Labs | British Columbia, Canada, Vancouver |
| Maryland Health Care Product Development | Maryland, Rockville, United States |
| Microsoft for Startups | Redmond, United States, Washington |
| PacRim Venture Partners | California, Menlo Park, United States |
| Positive Ventures | Brazil, São Paulo, São Paulo |
| Relentless Pursuit Partners | British Columbia, Canada, Vancouver |
| Sauzalito Ventures | California, Sausalito, United States |
| Top Technology Ventures | England, London, United Kingdom |
| TRANSSION | China, Guangdong, Shenzhen |
| Zhulu Capital | China, Shanghai |
| Zhuoyuan Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Yuanyi Biotech | $15M | 18 Oct 2023 | Guangdong, Tianjin, China | ||
Hengyu Medical | $15M | 18 Jul 2023 | Guangdong, Tianjin, China | ||
Hengyu Medical | 07 Jan 2022 | Guangdong, Tianjin, China | |||
Micot | $55M | 22 Jun 2021 | China, Wuwei, China | ||
Global Health Ark Medical Technology | $7M | 06 May 2021 | Beijing, Beijing, China | ||
| $17M | 16 Oct 2019 | China, Wuwei, China | |||
HOZ Medical | $8M | 31 Jan 2018 | Dongcheng District, Beijing, China | ||
Shequ580 | 10 Jan 2018 | Yuexiu District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Hegea Bio | $15M | 28 Mar 2024 | Shanghai, Shanghai, China | ||
Yuanyi Biotech | $15M | 18 Oct 2023 | Guangdong, Tianjin, China | ||
Hengyu Medical | $15M | 18 Jul 2023 | Guangdong, Tianjin, China | ||
Hengyu Medical | 07 Jan 2022 | Guangdong, Tianjin, China | |||
Micot | $55M | 22 Jun 2021 | China, Wuwei, China | ||
Global Health Ark Medical Technology | $7M | 06 May 2021 | Beijing, Beijing, China | ||
| $17M | 16 Oct 2019 | China, Wuwei, China | |||
HOZ Medical | $8M | 31 Jan 2018 | Dongcheng District, Beijing, China | ||
Shequ580 | 10 Jan 2018 | Yuexiu District, Guangdong Province, China |
